artemether
Selected indexed studies
- Artemether for severe malaria. (Cochrane Database Syst Rev, 2019) [PMID:31210357]
- Artemether for severe malaria. (Cochrane Database Syst Rev, 2014) [PMID:25209020]
- Artemether-lumefantrine for uncomplicated malaria: a systematic review. (Trop Med Int Health, 2004) [PMID:15040555]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Artemether for severe malaria. (2019) pubmed
- Artemether for severe malaria. (2014) pubmed
- Artemether-lumefantrine for uncomplicated malaria: a systematic review. (2004) pubmed
- Artemether ameliorates DSS-induced ulcerative colitis by modulating macrophage polarization. (2025) pubmed
- Artemether ameliorates adriamycin induced cardiac atrophy in mice. (2023) pubmed
- Artemether for severe malaria: a meta-analysis of randomized clinical trials. (1999) pubmed
- The potential of artemether for the control of schistosomiasis. (2001) pubmed
- Artemether exerts neuroprotective effect in Parkinson's disease through the PI3K/Akt/GSK-3β signaling pathway. (2025) pubmed
- Artemether-lumefantrine for treating uncomplicated falciparum malaria. (2003) pubmed
- Coartemether (artemether and lumefantrine): an oral antimalarial drug. (2004) pubmed